New drug could save your puppy's life

2014-06-02 08:45

(Shutterstock)

Multimedia   ·   User Galleries   ·   News in Pictures Send us your pictures  ·  Send us your stories

Grand Forks - A US company has discovered an antibody technology, while trying to cure flocks of dying geese, and will use its research for a more warm and fuzzy purpose: Saving puppies.

Early tests performed on about 50 puppies in seven US states for Grand Forks-based Avianax have resulted in a 90% cure rate for canine parvovirus, which spreads through animal waste and direct contact between dogs, usually at kennels, shelters and shows.

Some puppies die from the virus and others are euthanized because the antibiotics and other medicine needed to treat it can be too expensive, sometimes up to $2 000.

It isn't clear how many dogs contract parvo annually, since the disease isn't required to be reported. At the Kansas City Pet Project, one of eight test sites and among the largest shelters in the United States, about five cases a month wind up on the "parvo ward".

Officials with the Missouri shelter believe the treatment will lead to a dramatic increase in their "parvo graduates".

"When the box arrived we were yelling, 'Woo, the geese antibodies are here!'" shelter spokesperson Tori Fugate said. "Just the fact that someone is caring out there is pretty remarkable. A lot of open admission shelters choose to not treat parvo because it's considered too much of a resource."

Avianax chief operating officer Richard Glynn hopes to start selling the parvoONE antibody-based treatment, that is, harvested from the yokes of goose eggs, for $75 a dose by next spring.

"I think there will be a lot of puppy owners who will be very happy", Glynn said.

The US department of agriculture issued a conditional permit for the field trials that are taking place.

Such permits are normally reserved for outbreaks or other dire situations, but this one passed muster because there's no product specifically targeted for parvovirus, said Jeremy Vrchota, Avianax's sales director and regulatory liaison.
Read more on:    us  |  animals  |  health  |  research

Join the conversation!

24.com encourages commentary submitted via MyNews24. Contributions of 200 words or more will be considered for publication.

We reserve editorial discretion to decide what will be published.
Read our comments policy for guidelines on contributions.
NEXT ON NEWS24X

24.com publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
0 comments
Comments have been closed for this article.

Inside News24

 
/News

Book flights

Compare, Book, Fly

Traffic Alerts
There are new stories on the homepage. Click here to see them.
 
English
Afrikaans
isiZulu

Hello 

Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.


Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire 24.com network.

Settings

Location Settings

News24 allows you to edit the display of certain components based on a location. If you wish to personalise the page based on your preferences, please select a location for each component and click "Submit" in order for the changes to take affect.




Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.